WAKEFIELD, MA--(Marketwired - Aug 24, 2016) -  The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that four new life sciences and technology organizations have joined the Foundation as Silver Members in the first half of 2016. BioSci Consulting, Boehringer Ingelheim, Imperial College London, and ITTM each have made substantial financial contributions to the Foundation and become active participants of the tranSMART community.

"We welcome these four additional organizations to the tranSMART community," said tranSMART Foundation CEO Keith Elliston, PhD. "We rely on the varying expertise of our member organizations to develop and deliver such a robust open-source platform and help further the development of precision medicine. It is through the support of our member organizations that we are able to continue to enhance the platform and expand into new areas to fulfill our mission and realize the promise that translational biomedical research has to offer."

BioSci Consulting, Boehringer Ingelheim, Imperial College London, and ITTM have all joined as Silver Members. Each of these organizations have made a minimum investment of $5,000 to $20,000 to help fund the Foundation's operations. They also have the opportunity to submit a representative to a pool of candidates to be elected the Foundation's board, and can nominate one individual to one of the Foundation's 3C's (Code, Content and Community) committees. For more information on the tranSMART Membership Program, please visit the Foundation website.

The current members of the tranSMART Foundation, include:

Gold: Pfizer, Roche, Sanofi, Takeda, and the University of Michigan
Silver: Abbvie, Assurex, BioSci Consulting, Boehringer Ingelheim, ConvergeHEALTH by Deloitte, DEXSTR, the Hyve, IO Informatics, Imperial College London, ITTM, One Mind, PerkinElmer, Philips, Rancho Biosciences, and Thomson Reuters
Affiliate: Elevada and Harvard University

In addition to the support of its member organizations, the tranSMART Foundation's Corporate Sponsors help support the organizations multiple events held throughout the year. The current 2016 Corporate Sponsors include: epam, GeneDx and Rancho Biosciences.

About The tranSMART Foundation
The tranSMART Foundation is a non-profit organization that provides an open-source, cloud-based, data-sharing and analysis platform that enables scientists at universities, disease foundations, pharmaceutical companies, and government agencies around the world to share pre-competitive data in a way that saves money and time in translating research findings into new therapies and diagnostic tools. Current Gold Members of the Foundation include: Pfizer, Roche, Sanofi, Takeda, and the University of Michigan. Founded to steward the tranSMART platform, the Foundation is headquartered in Wakefield, Massachusetts with Centers of Excellence in Ann Arbor, Mich.; London, England; Boston, Mass.; and Amsterdam, Netherlands. The tranSMART Foundation can also be found on the web at www.tranSMARTFoundation.org.

Contact Information:

Karen Higgins
A&E Communications, Inc.